Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of NXsignal Applied Surface Neurostimulation Technology for the Treatment of Type I Complex Regional Pain Syndrome (CRPS I)

NCT05052736 is registered in ClinicalTrials.gov with University of Las Palmas de Gran Canaria as lead sponsor.

NCT NCT05052736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05052736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of NXsignal Applied Surface Neurostimulation Technology for the Treatment of Type I Complex Regional Pain Syndrome (CRPS I)
Lead sponsor
University of Las Palmas de Gran Canaria
Phase
Not applicable
Overall status
Recruiting
Start date
March 28, 2022
Completion date
December 27, 2026
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type i complex regional pain syndrome